Pain in Parkinson's Disease
Conditions
Interventions
Intervention Group: 40 patients will be subjected to Transcutaneous Nerve Electrical Stimulation in the active form, lasting 30 minutes, 2 times a week over 5 weeks.
Placebo group: 40 patients will be
Other
Sponsors
Universidade Federal de Sergipe
Universidade Federal de Sergipe
Eligibility
Age
45 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria comprehend:subjects of both sexes and aged between 50 and 80 years; presence of motor fluctuations; conventional antiparkinsonian therapy excluding amantadine , clozapine, deep brain stimulation or pallidotomy and previous thalamotomy; ability to remain standing for at least 10 minutes; ability to walk independently with or without assistive devices; complaint of pain in the spine, with the presence or absence of irradiation to limbs and characterized as neuropathic (continuous and diffuse spontaneous pain, sensory loss, allodynia and hyperalgesia). Targer sample 80 patients.
Exclusion criteria
Exclusion criteria: Subjects will be excluded if: the medical or physical examination scores below 24 on the Mini Mental State Examination; there are systemic conditions, such as heart disease, that would interfere with the participation in the study; there is musculoskeletal damage or excessive pain in any joint that may limit participation in an exercise program; there is psychiatric disorder, cognitive decline or dementia influencing the communication process; there is musculoskeletal, cardiopulmonary or neuromuscular disorder ,recent or unresolved, which may affect their ability to walk or mobility; they are under physiotherapeutic treatment during the period of training; there is presence of contraindications for use of TENS, such as ulcerations or allergy to the material; there was previous use of TENS; there is chronic use of opioids or antidepressants; there is use of a cardiac pacemaker; there is reduced sensitivity at sites where the electrodes will be placed; there was previous back surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduced pain intensity in patients with Parkinson's disease verified by comparing the values collected before and after application of TENS the following assessment instruments: number scale of 11 points, pressure algometer and test of conditioned pain modulation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in central sensitization, skin sensitivity, motor performance, gait speed, static and dynamic balance, torso mobility, muscle stiffness and hypertonia, muscle flexibility, pain catastrophizing, depression and life quality during the period of TENS application verified using the following assessment tools: temporal summation, esthesiometry, Timed Up and Go test, accelerometry, figure 8 test, baropodometry, torso mobility scale, Modified Ashworth scale, fleximetry, pain catastrophizing scale, Beck’s depression Inventory and Unified Parkinson's Disease Rating Scale. | — |
Countries
Brazil
Contacts
Public ContactJosimari;Priscila Santana;Garcez
Universidade Federal de Sergipe;Universidade Federal de Sergipe
Outcome results
None listed